Patents by Inventor Stefanos Grammatikos

Stefanos Grammatikos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090162900
    Abstract: An expression vector for eukaryotic cells comprising a gene which codes for a protein of interest, functionally linked to a hamster-ubiquitin/S27a-promoter and a gene which codes for a fluorescent protein. Preferably the expression vector also contains an amplifiable selectable marker gene. The invention also describes host cells, preferably mammalian cells, which have been transfected with the expression vector, processes for producing heterologous gene products and a method of selecting high-producing cells.
    Type: Application
    Filed: February 15, 2008
    Publication date: June 25, 2009
    Inventors: Barbara ENENKEL, Juergen Fieder, Ralf Otto, Stefanos Grammatikos
  • Patent number: 7384744
    Abstract: An expression vector for eukaryotic cells comprising a gene which codes for a protein of interest, functionally linked to a hamster-ubiquitin/S27a-promoter and a gene which codes for a fluorescent protein. Preferably the expression vector also contains an amplifiable selectable marker gene. The invention also describes host cells, preferably mammalian cells, which have been transfected with the expression vector, processes for producing heterologous gene products and a method of selecting high-producing cells.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: June 10, 2008
    Assignee: Boehringer Ingelheim Pharma GmbH & Co., KG
    Inventors: Barbara Enenkel, Juergen Fieder, Ralf Otto, Stefanos Grammatikos
  • Publication number: 20040148647
    Abstract: An expression vector for eukaryotic cells comprising a gene which codes for a protein of interest, functionally linked to a hamster-ubiquitin/S27a-promoter and a gene which codes for a fluorescent protein. Preferably the expression vector also contains an amplifiable selectable marker gene.
    Type: Application
    Filed: November 26, 2003
    Publication date: July 29, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Barbara Enenkel, Juergen Fieder, Ralf Otto, Stefanos Grammatikos